Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Phase 2

Completed

• Conditions: Hepatitis C

• Registration Number: NCT00446940
• Lead Sponsor: Bader, Ted, M.D.

Brief Summary

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-12
• Study Completion: 2007-03
• Study First Submitted: 2007-03-11
• Study First Submitted QC: 2007-03-12
• Study First Posted: 2007-03-13
• Status Verified: 2008-09
• Last Update Submitted: 2008-09-08
• Last Update Posted: 2008-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Hepatitis C

Exclusion Criteria

• HIV positivity

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

VA Hospital; 🇺🇸 OKlahoma City, Oklahoma, United States